Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Logo for the C.L. de Carvalho- Heineken Prize is on the left side, and on the right is a photo of Kia Nobre standing in front of a hallway of stone arched windows

Huge congratulations to Kia Nobre, Professor of Translational Cognitive Neuroscience, for being awarded the C.L. de Carvalho-Heineken Prize for Cognitive Science 2022. The award honours her innovative approach to imaging and understanding the human brain as well as the impact of this work on numerous subfields of cognitive neuroscience, including attention, working memory, long-term memory, and language. The Heineken Prizes – awarded every two years to five distinguished researchers – are the Netherlands’ most prestigious international science prizes. 

The selection jury (with chair Roshan Cools, Professor of Cognitive Neuropsychiatry at Radboud University Nijmegen and the Donders Institute for Brain, Cognition, and Behaviour) was impressed not only by the depth but also by the breadth of Kia's research, and its impact. It identified her as a pioneering and distinguished researcher who has helped to pioneer the transition from cognitive psychology to cognitive neuroscience. Kia was among the first to use several revolutionary techniques to image the brain. For example, early in her career, she measured brain activity via electrodes in the brains of epilepsy patients who had had these electrodes implanted. This led to the discovery of new areas of the brain that play a role in processing words, a major breakthrough in understanding the language network in the human brain. The jury also recognises her commitment to promoting diversity and inclusion, for her exceptional mentoring and leadership skills, and calls her a role model for women scientists.

Kia said:

I’m deeply humbled and over the moon to receive the C.L. de Carvalho-Heineken Prize for Cognitive Neuroscience. I feel beyond lucky to be at the confluence of so many inspirations, influences, perspectives, ideas, methodological know-how, and empirical investigations of so many talented and generous people. Thank you to my wonderful mentors, students, research fellows, and colleagues. For [my husband] Luciano’s boundless love and support, there simply are no words.

 

Read the full story on the Department of Experimental Psychology website. 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience